Bailón, L., Llano, A., Cedeño, S., Escribà, T.
, Rosás-Umbert, M., Parera, M., Casadellà, M., Lopez, M., Pérez, F., Oriol-Tordera, B., Ruiz-Riol, M., Coll, J., Perez, F., Rivero, À., Leselbaum, A. R., McGowan, I., Sengupta, D., Wee, E. G., Hanke, T. ... the AELIX002 Study Group (2022).
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.
Nature Medicine,
28(12), 2611-2621.
https://doi.org/10.1038/s41591-022-02060-2